PTT: Issue No.2 - TWO WAVES CONVERGE
Peaks, Troughs & Trends
Two Waves Converge
Digital health is consolidating. Value-based care is going national. And in the background, the financial floor under healthcare keeps moving — for employers, for Medicare, and for the systems that serve everyone in between.
- Risant Health (Kaiser) finalizes Geisinger acquisition with $5 billion committed to a value-based care platform; 4 to 5 more systems planned.
- Abbott announces $21 billion acquisition of Exact Sciences — the largest diagnostics M&A of 2026, expected to close in Q2.
- Ohio Medicare patients now require AI prior authorization under the WISER pilot, with algorithms screening 14 procedures.
- CMS proposes 0.09% Medicare Advantage rate increase for 2027 — effectively flat against 3 to 5% cost inflation.
- Employer premiums + deductibles exceed 10% of income in 19 states, with Louisiana highest at 15.6% (Commonwealth Fund).
- Healthcare hiring rebounds: clinical openings up 20%, applications up 10% month over month (iCIMS).
Digital Health M&A Wave Materializes
After years of "wait and see," digital health consolidation has entered a new phase. In the past month alone: Sword Health acquired Kaia Health for $285M, Spring Health acquired Alma, NOCD acquired Rebound, Wisp announced acquisition plans, and OpenAI acquired Torch for $60M. The acquirers are VC-backed companies scaling through consolidation — not defensive payers or health systems buying optionality. This is digital health's maturation moment.2
SourceMedCity News
Risant Health Closes Geisinger, Building a Value-Based Care Empire
Kaiser Permanente's Risant Health vehicle finalized its acquisition of Geisinger Health, committing $5 billion to build a national value-based care platform. The plan calls for 4 to 5 additional health system acquisitions. This is not traditional consolidation for scale; it is a deliberate effort to create a national network of systems operating under value-based contracts, following the Kaiser model of integrated care delivery and financing.3
Abbott + Exact Sciences: Diagnostics as Strategic Growth Engine
Abbott's $21 billion acquisition of Exact Sciences validates a thesis that has been building for years: diagnostics is no longer a commodity, it is a strategic differentiator. The deal follows the Roche model of integrating diagnostics with therapeutics and positions Abbott for cancer screening, early detection, and precision medicine. KPMG separately surveyed 500 healthcare executives and found leaders "bullish" on M&A despite macroeconomic headwinds.4
SourcesPharmExec, Chief Healthcare Executive
Employer Health Coverage Hits Affordability Crisis
A Commonwealth Fund analysis found that combined employer premiums and deductibles now consume more than 10% of household income in 19 states. Louisiana leads at 15.6%. The acceleration is notable: the ACA subsidy cliff is compounding the problem. Tenet Healthcare expects a 20% drop in exchange enrollment as enhanced subsidies expire, and premiums are doubling for many enrollees above 400% of the federal poverty level.5
SourcesAJMC, Healthcare Labyrinth
AI Prior Authorization Enters Traditional Medicare
The CMS WISER pilot is now live in Ohio, using algorithms to screen 14 procedures for traditional Medicare beneficiaries. This marks the first time AI has been deployed for prior authorization in traditional Medicare, affecting more than 30 million beneficiaries if expanded nationally. The pilot raises questions about algorithmic bias, appeal processes, and whether AI-driven decisions will receive the same scrutiny as human reviewers.6
SourcesStatehouse News, Fast Company
Medicaid Cuts Could Shift $1.1 Trillion to States
Managed Healthcare Executive analysis shows that proposed Medicaid cuts could shift $1.1 trillion in costs to states through 2034. Federal matching amplifies the impact: every dollar cut from federal Medicaid triggers additional state spending reductions. Thirty-two percent of Medicaid funds go directly to hospital care. For Medicaid-dependent systems, especially those in underserved markets, this is an existential financial threat.7
Digital Health Consolidation Enters Its Mature Phase
The acquirers in the current wave of digital health M&A are not legacy health systems or payers buying innovation; they are VC-backed digital health companies buying each other. Sword Health, Spring Health, and NOCD are all scaling through acquisition rather than organic growth. This signals that the digital health market has matured past its "thousand flowers blooming" phase into a consolidation cycle where proven models absorb adjacent capabilities.8
SourceMedCity News
Value-Based Care Expansion Via Acquisition
Risant Health's model — acquiring existing health systems and converting them to value-based operations — could reshape the nonprofit consolidation playbook. Unlike traditional mergers driven by scale and market share, Risant's thesis is operational: value-based care infrastructure deployed across multiple regional systems. If it works, this becomes the template for the next decade of nonprofit health system transactions.9
AI Denial Risk Enters Public Insurance
The WISER pilot sets a precedent: if AI-driven prior authorization works in traditional Medicare, it will expand. The Kaiser strike, now involving 34,000 or more workers, has become California's first major AI labor dispute, with workers demanding safeguards against AI-driven workflow changes. These two developments — AI in public insurance and AI as a labor flashpoint — are converging into a single structural challenge for 2026.10
SourcesLA Times, The Conversation
So What
For Professionals
Two consolidation waves are converging this week, and both reshape your career landscape. Digital health companies are buying each other — which means the startup you work for (or might join) is more likely to be acquired than to IPO. Meanwhile, Risant Health's model creates new leadership roles at the intersection of value-based care operations and system integration. If you are in clinical AI, the WISER pilot means your workflow is about to include prior authorization algorithms. Understand how they work before they govern your referrals.
For Leaders & Operators
The 0.09% MA rate proposal is the financial signal of the week. When CMS offers a rate increase that amounts to a real-dollar cut against 3 to 5% cost inflation, margin planning must adjust immediately. Pair that with the $1.1 trillion Medicaid cost shift analysis and the employer affordability crisis (10%+ of income in 19 states), and the revenue picture for 2027 is materially different than what most systems budgeted. Diversifying payer mix and accelerating value-based transitions are no longer aspirational goals; they are survival strategies.
For Builders & Investors
Capital is making clear choices. The Abbott/Exact Sciences deal at $21 billion validates diagnostics as a premium acquisition category. Digital health M&A shows VC-backed companies buying scale rather than building it. The Risant model creates investment opportunities in value-based care infrastructure, operational tools, and integration platforms. The investable categories right now: diagnostic platforms, digital health consolidation plays, value-based care infrastructure, and AI governance tools.
- HIMSS 2026Las Vegas, Nevada March 3–6
- HLTH 2026Las Vegas, Nevada October